Therapeutic Solutions International: Funding & Investors (Oct 2026)
Therapeutic Solutions International is a biotechnology company engaged in the development of products for females. The company offers Vital which helps its users stay active; ProJuvenol, an anti-ageing solution that helps promote cellular rejuvenation and healthy functionality for everyday living; and T-Rx which enables its users to control their levels of estrogen. Therapeutic Solutions International is based in California, United States.
Therapeutic Solutions International has raised $10.0M across 1 funding round on record, the most recent a Post-IPO Equity of $10.0M announced in Sep 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Therapeutic Solutions International Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Therapeutic Solutions International Funding Rounds
Therapeutic Solutions International Founders and Leadership Team
No contact details are on record for this team yet.
Therapeutic Solutions International Funding Compared to Other Biotechnology Startups
Therapeutic Solutions International's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Therapeutic Solutions International in Biotechnology and Oceanside
Companies Similar to Therapeutic Solutions International
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Therapeutic Solutions International Funding FAQs
What does Therapeutic Solutions International do?
Therapeutic Solutions International is a biotechnology company engaged in the development of products for females. The company offers Vital which helps its users stay active; ProJuvenol, an anti-ageing solution that helps promote cellular rejuvenation and healthy functionality for everyday living; and T-Rx which enables its users to control their levels of estrogen. Therapeutic Solutions International is based in California, United States.
How much funding has Therapeutic Solutions International raised?
Therapeutic Solutions International has raised $10.0M across 1 round on record. The most recent is a Post-IPO Equity of $10.0M announced in Sep 2022.
When did Therapeutic Solutions International last raise funding?
Therapeutic Solutions International's most recent funding round on record is a Post-IPO Equity of $10.0M, announced in Sep 2022.
Who is the CEO of Therapeutic Solutions International?
Tim Dixon is listed as CEO at Therapeutic Solutions International.
Where is Therapeutic Solutions International headquartered?
Therapeutic Solutions International is based in Oceanside, California, United States.
How many employees does Therapeutic Solutions International have?
Therapeutic Solutions International is in the 1-10 employee band.
How does Therapeutic Solutions International's funding compare to other Biotechnology startups?
Therapeutic Solutions International's latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Therapeutic Solutions International Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Therapeutic Solutions International is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.